Biomerica reports real-world data showing IBS therapy effectiveness
Go back to Biomerica reports real-world data showing IBS therapy effectiveness| Biomerica, Inc. (NASDAQ: BMRA) | Delayed: 1.92 -0.05 (2.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.97 | 52 Week High | $3.25 | |||
| Open | $1.95 | 52 Week Low | $0.80 | |||
| Day High | $1.95 | P/E | N/A | |||
| Day Low | $1.87 | EPS | $-0.06 | |||
| Volume | 18,674 | |||||
| Henry Schein, Inc. (NASDAQ: HSIC) | Delayed: 77.60 -2.57 (3.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.17 | 52 Week High | $183.00 | |||
| Open | $79.27 | 52 Week Low | $142.64 | |||
| Day High | $79.39 | P/E | 15.74 | |||
| Day Low | $76.89 | EPS | $4.93 | |||
| Volume | 1,724,802 | |||||
